Home>News Center>China
       
 

Roche in talks for Tamiflu production in China
(AP)
Updated: 2005-10-31 15:47

Swiss drug company Roche is in talks with China about jointly producing its antiviral medication Tamiflu, a move that could boost its global production amid fears supplies will fall short of what is needed in case of a flu pandemic, reports said Monday.

"We are talking with a number of Chinese authorities to see what is the best way to address the issue at this point," the Hong Kong newspaper South China Morning Post quoted Roche's chairman and chief executive officer Franz Humer as saying at a weekend conference of business and city leaders in Shanghai.

"We are certainly in discussions," Humer said.

Roche Holding AG has been inundated with requests from other pharmaceutical companies for licences to produce Tamiflu, the drug experts believe to be the best defence against a possible flu pandemic.

The company's Shanghai office confirmed that like its branches elsewhere, "in view of the increasing urgency of the situation," it was open to discussing production with any potential partner with a capacity to make substantial amounts of the drug that would meet quality, safety and regulatory specifications.

"Roche is doing everything to increase its supply," the company said in a statement, adding that it expects to have increased production as much as ten-fold by mid-2006, on its own.

Roche's office in Shanghai refused to comment by telephone and did not immediately respond to a written inquiry on Monday.

Reports in Chinese newspapers said Roche had not yet received any formal applications from pharmaceutical companies in the Chinese mainland.

The reports also questioned the ability of companies inside China to make the drug, given its complex production process.

Nearby Taiwan has announced plans to make large quantities of Tamiflu and is seeking authorization from Roche, although its "National Health Research Institute" says it is able to make the drug independently.

Health authorities are hoping to boost stockpiles of Tamiflu in case the deadly H5N1 strain of bird flu spreading from Asia to Europe mutates into a form that can pass easily to and between people, setting off a human flu pandemic before a vaccine can be developed.

China has reported three bird flu outbreaks in poultry over the past month. No human cases have been reported.

Roche, based in Basel, Switzerland, opened a research and development centre in Shanghai a year ago and is building a factory that is expected to produce its transplant medication CellCept and chemotherapy drug Xeloda for China by next year.



President Hu in Hanoi
Miss Chinese Cosmos 2005
China controls outbreak of bird flu
  Today's Top News     Top China News
 

Hu's visit to Viet Nam takes ties to new high

 

   
 

China critic gets key cabinet post in Japan

 

   
 

East Asia Community taking shape

 

   
 

Water crisis needs urgent solutions

 

   
 

Killer gas to become beneficial

 

   
 

Foreign trade growth to lose momentum

 

   
  China falling victim to trade protectionism
   
  Shanghai accelerates service-based economy
   
  Fragrant Hills draws crowds
   
  Relief team reaches quake-hit Pakistan
   
  2000-year-old Mummy deteriorating
   
  Residents to be relocated from wetland
   
 
  Go to Another Section  
 
 
  Story Tools  
   
  News Talk  
  It is time to prepare for Beijing - 2008  
Advertisement